Although it has been reported that induction of peroxisome proliferator-activated receptor delta (PPARδ) drives KCs toward the M2 form, reducing obesity-induced insulin resistance in mice [172], the role of M2 KCs in NAFLD is still not elucidated [168]. This evidence concerns the gene TBCE and metabolic dysfunction-associated steatotic liver disease.